Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus

Journal of Hospital Infection

Volumn 40, Issue SUPPL. B, 1998, Pages

  Kluytmans, J ^a  

^a Ignatius Hospital   (Netherlands)

Author keywords

Hospital infections; Mupirocin; Nasal carriage; Staphylococcus aureus infections; Surgical site infections

Indexed keywords

PSEUDOMONIC ACID;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; HOSPITAL PATIENT; HUMAN; INTRANASAL DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NOSE; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; TOPICAL DRUG ADMINISTRATION;

EID: 0031727069     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(98)90201-8     Document Type: Conference Paper

References (26)

1. Kluytmans JAJW, Mouton JW, Ijzerman EPF et al. Nasal carriage of S. aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171: 216-219.
2. Yzerman EPF, Boelens HAM, Tjhie JHT, Kluytmans JAJW, Mouton JW, Verbrugh HA. ΔAPACHE II for predicting course and outcome of nosocomial S. aureus bacteremia and its relation to host defence. J Infect Dis 1996; 173: 914-919.
3. Voss A, Doebbeling BN. The worldwide prevalence of methicillin-resistant S. aureus. Int J Antimicrob Agents 1995; 5: 101-106.
4. Williams REO. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963; 27: 56-71.
5. Parras F, del Carmen Guerrero M, Bouza E et al. Comparative study of mupirocin and oral cotrimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant S. aureus. Antimicrob Agents Chemother 1995; 39: 175-179.
6. Reagan DR, Doebbeling BN, Pfaller MA et al. Elimination of coincident S. aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114: 101-106.
7. Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clin Microbiol Rev 1997; 10: 505-520.
8. Pujol M, Pena C, Pollares R et al. Nosocomial S. aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996; 100: 509-516.
9. Snydman DR, Sullivan B, Gill M, Gould JA, Parkinson DR, Atkins MB. Nosocomial sepsis associated with interleukin-2. Ann Int Med 1990; 112: 102-107.
10. Weinke T, Schiller R, Fehrenbach FJ, Pohle HD. Association between S. aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992; 11: 985-989.
11. Stegeman CA, Cohen Tervaert JWC, Sluiter WJ, Manson WL, de Jong PE, Kallenber CGM. Association of chronic nasal carriage of S. aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 1994; 120: 12-17.
12. Colbeck JC, Robertson HR, Sutherland WH, Hartley FC. The importance of endogenous staphylococcal infections in surgical patients. Can Serv Med J 1959; 15: 326-331.
13. Weinstein HJ. The relation between nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med 1959; 260: 1303-1310.
14. Williams REO, Jevons MP, Shooter RA et al. Nasal staphylococci and sepsis in hospital patients. BMJ 1959; ii: 658-662.
15. Calia FM, Wolinsky E, Mortimer EA, Abrams JS, Rammelkamp CH. Importance of the carrier state as a source of S. aureus in wound sepsis. J Hyg (Camb) 1969; 67: 49-57.
16. White A. Increased infection rates in heavy nasal carriers of coagulase-positive staphylococci. Antimicrob Agents Chemother 1963; 30: 667-670.
17. Bruun JN. Postoperative wound infection. Predisposing factors and the effect of a reduction in the dissemination of staphylococci. Acta Med Scand 1970; 514 (Suppl): 1-89.
18. Kluytmans JAJW. Nasal carriage of S. aureus: the key to preventing staphylococcal disease. PhD thesis. Rotterdam, Erasmus University 1996.
19. Williams REO, Blowers R, Garrod LP, Shooter RA. Hospital infection, causes and prevention. 2nd edn. London: Lloyd-Luke Medical Books 1966.
20. Boelaert JR. S. aureus infection in hemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. J Chemother 1994; 6 (Suppl 2): 19-24.
21. Gould JC, Allan WSA. Staphylococcus pyogenes cross-infection: prevention by treatment of carriers. Lancet 1954; ii: 988-989.
22. Henderson RJ, Williams REO. Nasal disinfection in prevention of post-operative staphylococcal infection of wounds. BMJ 1961; ii: 330-333.
23. Stokes EJ, Milne SE. Effect of Naseptin cream prophylaxis on staphylococcal infection in adult surgical wards and infant nurseries. J Hyg (London) 1962; 60: 209-215.
24. Rountree PM, Loewenthal J, Tedder E, Gye R. Staphylococcal wound infection: the use of neomycin and chlorhexidine ('Naseptin') nasal cream in its control. Med J Aust 1962; 2: 367-370.
25. Kluytmans JAJW, Mouton JW, VandenBergh MFQ et al. Reduction of surgical site infections in cardiothoracic surgery by elimination of nasal carriage of S. aureus. Infect Control Hosp Epidemiol 1996; 17: 780-785.
26. VandenBergh MFQ, Kluytmans JAJW, van Hout BA et al. Cost-effectiveness of peri-operative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol 1996; 17: 786-792.